Literature DB >> 24943287

The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents.

J A de Miranda1, R Lacchini2, V A Belo2, C M M Lanna3, J T Sertorio1, M R Luizon2, J E Tanus-Santos2.   

Abstract

Obesity and the nitric oxide synthase 3 (NOS3) gene polymorphisms are associated with nitrite levels and hypertension. However, no study has tested the hypothesis that NOS3 tagSNPs rs3918226, rs3918188, rs743506 and rs7830 affect nitrite levels and are associated with hypertension in childhood obesity. We investigated the association of these NOS3 tagSNPs and the haplotypes formed by them with hypertension and with nitrite levels in children and adolescents with obesity and with obesity plus hypertension. We studied 355 subjects: 174 healthy (controls), 109 normotensive obese, and 72 obese children and adolescents with obesity plus hypertension. Genotypes were determined by Taqman allele discrimination assay and real-time PCR. We compared the distribution of NOS3 tagSNP genotypes, alleles and haplotypes in the three groups of subjects. Nitrite levels were determined by ozone-based chemiluminescence. Nitrite levels were affected by the rs3918226 polymorphism (P<0.05) but not by NOS3 haplotypes. There was no association between the tagSNPs studied and hypertension in children and adolescents. Our findings show that the NOS3 tagSNP rs3918226 is associated with NO production in children and adolescents, and suggest that this polymorphism may have an impact on cardiovascular health. Further studies are needed to better clarify the effects of this polymorphism on cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24943287     DOI: 10.1038/jhh.2014.48

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  43 in total

1.  Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms.

Authors:  Aline S Marroni; Ingrid F Metzger; Debora C Souza-Costa; Sabrina Nagassaki; Valeria C Sandrim; Ronan X Correa; Fabricio Rios-Santos; Jose E Tanus-Santos
Journal:  Nitric Oxide       Date:  2005-05       Impact factor: 4.427

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice.

Authors:  Jeong-Ho Oak; Hua Cai
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

4.  Childhood obesity, other cardiovascular risk factors, and premature death.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

5.  Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus.

Authors:  Valéria C Sandrim; Roger W C de Syllos; Hugo R K Lisboa; Glaucia S Tres; Jose E Tanus-Santos
Journal:  Atherosclerosis       Date:  2006-01-20       Impact factor: 5.162

6.  Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine.

Authors:  Flavia M Gonçalves; Alisson Martins-Oliveira; Jose G Speciali; Marcelo R Luizon; Tatiane C Izidoro-Toledo; Pamela S Silva; Fabiola Dach; Jose E Tanus-Santos
Journal:  DNA Cell Biol       Date:  2011-02-20       Impact factor: 3.311

7.  Leptin-induced endothelial dysfunction in obesity.

Authors:  Mykhaylo Korda; Ruslan Kubant; Stephen Patton; Tadeusz Malinski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

Review 8.  Adiponectin: an update.

Authors:  M Guerre-Millo
Journal:  Diabetes Metab       Date:  2008-02       Impact factor: 6.041

9.  Serum nitric oxide metabolites in subjects with metabolic syndrome.

Authors:  Saleh Zahedi Asl; Asghar Ghasemi; Fereidoun Azizi
Journal:  Clin Biochem       Date:  2008-09-03       Impact factor: 3.281

Review 10.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015

View more
  3 in total

1.  Is high waist circumference and body weight associated with high blood pressure in Iranian primary school children?

Authors:  Mitra Zarrati; Elham Hojaji; Elham Razmpoosh; Farinaz Nasiri Nezhad; Hossein Keyvani; Raheleh Shokouhi Shoormasti; Farzad Shidfar
Journal:  Eat Weight Disord       Date:  2016-08-04       Impact factor: 4.652

2.  Association of eNOS Gene Polymorphisms G894T and T-786C with Risk of Hepatorenal Syndrome.

Authors:  Yuksel Seckin; Ali Yigit; Elif Yesilada; Gonca Gulbay; Yasir Furkan Cagin; Harika Gozukara; Yılmaz Bılgıc; Oguzhan Yildirim; Yusuf Turkoz; Zeynep Aksungur
Journal:  Gastroenterol Res Pract       Date:  2016-08-10       Impact factor: 2.260

3.  Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and metabolic syndrome in healthy subjects and schizophrenia patients.

Authors:  Nikolai Fattakhov; Liudmila Smirnova; Dmitriy Atochin; Daria Parshukova; Daria Skuratovskaia; Quinn Painter; Pavel Zatolokin; Arkadiy Semke; Larisa Litvinova; Svetlana Ivanova
Journal:  Int J Obes (Lond)       Date:  2018-06-15       Impact factor: 5.095

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.